Cognitive Effects of Treating Obstructive Sleep Apnea in Alzheimer's Disease: A Randomized Controlled Study
β Scribed by Sonia Ancoli-Israel; Barton W. Palmer; Jana R. Cooke; Jody Corey-Bloom; Lavinia Fiorentino; Loki Natarajan; Lianqi Liu; Liat Ayalon; Feng He; Jose S. Loredo
- Book ID
- 109130247
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 121 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0002-8614
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To assess the effects of Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) on simulated car driving ability. ## Methods Twenty patients with a probable AD of mild severity (Clinical Dementia Rating, CDRβ=β1) were compared with 20 subjects with MCI (CDβ=β0.5),
In a multinational, double-blind, placebo-controlled trial (NCT00474058), 287 subjects with Parkinson's disease (PD) and unsatisfactory early-morning motor symptom control were randomized 2:1 to receive rotigotine (2β16 mg/24 hr [n = 190]) or placebo (n = 97). Treatment was titrated to optimal dose
## Abstract Cognitive impairment can occur at all stages of Parkinson's disease. Rasagiline is a selective monoamine oxidase typeβB inhibitor that enhances central dopaminergic transmission. Dopamine is thought to be involved in certain cognitive processes such as working memory. We assessed the ef